Mycosis fungoides and its variants account for almost 50% of all cutaneous lymphomas and around 65% of cutaneous T-cell lymphomas. We report the clinical case of a patient with a tumoral nodule, with progressive evolution and rapid transformation. Our patient was undergoing chemotherapy. After mycosis fungoides, CD30+ cutaneous lymphoproliferations are the most frequent pathologies among cutaneous T-cell lymphomas, accounting for 20% of this group.
No takes yet. Share an insight, caveat, or question.
Keby et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: